William Blair started coverage on shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) in a research note published on Tuesday, July 18th, MarketBeat reports. The firm issued an outperform rating on the stock. William Blair also issued estimates for Acadia Healthcare’s Q2 2017 earnings at $0.64 EPS, Q3 2017 earnings at $0.67 EPS, Q4 2017 earnings at $0.67 EPS, FY2017 earnings at $2.44 EPS, FY2018 earnings at $2.82 EPS and FY2019 earnings at $3.11 EPS.
ACHC has been the subject of a number of other research reports. Zacks Investment Research upgraded shares of Acadia Healthcare from a sell rating to a hold rating in a research note on Friday, March 24th. Deutsche Bank AG started coverage on shares of Acadia Healthcare in a research note on Wednesday, April 5th. They issued a buy rating and a $53.00 price target for the company. Leerink Swann downgraded shares of Acadia Healthcare from an outperform rating to a market perform rating in a research note on Monday, May 15th. Jefferies Group LLC set a $55.00 price target on shares of Acadia Healthcare and gave the stock a buy rating in a research note on Thursday, June 1st. Finally, Cantor Fitzgerald reiterated a hold rating and issued a $45.00 price target on shares of Acadia Healthcare in a research note on Friday, March 24th. Five analysts have rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The company has a consensus rating of Buy and a consensus target price of $59.21.
Acadia Healthcare (NASDAQ ACHC) traded up 2.77% on Tuesday, hitting $52.38. 1,219,461 shares of the company traded hands. The firm has a market capitalization of $4.60 billion, a P/E ratio of 575.60 and a beta of 1.15. The stock’s 50-day moving average is $50.30 and its 200 day moving average is $44.67. Acadia Healthcare has a 12 month low of $32.54 and a 12 month high of $54.73.
Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Thursday, July 27th. The company reported $0.66 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.65 by $0.01. Acadia Healthcare had a net margin of 0.30% and a return on equity of 8.69%. The company had revenue of $715.90 million during the quarter, compared to the consensus estimate of $717.38 million. During the same quarter in the previous year, the firm earned $0.73 earnings per share. The firm’s quarterly revenue was down 5.4% on a year-over-year basis. Equities analysts forecast that Acadia Healthcare will post $2.45 EPS for the current fiscal year.
In other news, Director Reeve B. Waud sold 50,000 shares of Acadia Healthcare stock in a transaction on Friday, June 9th. The shares were sold at an average price of $45.09, for a total value of $2,254,500.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Christopher L. Howard sold 16,762 shares of Acadia Healthcare stock in a transaction on Thursday, August 3rd. The shares were sold at an average price of $52.47, for a total transaction of $879,502.14. Following the completion of the transaction, the executive vice president now directly owns 200,999 shares in the company, valued at $10,546,417.53. The disclosure for this sale can be found here. Insiders sold a total of 2,136,347 shares of company stock worth $105,383,249 over the last ninety days. Corporate insiders own 11.10% of the company’s stock.
A number of institutional investors have recently bought and sold shares of ACHC. BlackRock Inc. raised its position in Acadia Healthcare by 27,497.3% in the first quarter. BlackRock Inc. now owns 5,145,786 shares of the company’s stock worth $224,356,000 after buying an additional 5,127,140 shares during the period. Aristotle Capital Management LLC purchased a new position in Acadia Healthcare during the first quarter worth $140,071,000. William Blair Investment Management LLC raised its position in Acadia Healthcare by 1,247.4% in the second quarter. William Blair Investment Management LLC now owns 2,128,972 shares of the company’s stock worth $105,129,000 after buying an additional 1,970,965 shares during the period. FMR LLC raised its position in Acadia Healthcare by 173.2% in the first quarter. FMR LLC now owns 2,195,002 shares of the company’s stock worth $95,702,000 after buying an additional 1,391,552 shares during the period. Finally, Frontier Capital Management Co. LLC raised its position in Acadia Healthcare by 112.2% in the first quarter. Frontier Capital Management Co. LLC now owns 2,087,088 shares of the company’s stock worth $90,997,000 after buying an additional 1,103,446 shares during the period.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.